Medco Will Buy PolyMedica In $1.5 Billion Deal
This article was originally published in The Pink Sheet Daily
Acquisition expands Medco's presence in diabetes, where PolyMedica is best known for its Liberty brand of testing supplies.
You may also be interested in...
Driven by rising obesity rates, spending on diabetes therapies rose 14.5 percent from 2005 to 2006, firm’s annual Drug Trend Report states.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.